The targets of both miRNAs, miR-9-5p and miR-21-5p, include FREM2 and SPRY1, which could not be detected in the sEVs of GBM cell lines, and their expression was inverse to that of miRNA expression, suggesting the inhibition of gene expression. The gene discussed is SPRY1; the disease is glioblastoma.